Bringing together 25+ speakers and 60+ senior attendees from AstraZeneca, Genmab, Immunocore, Merus, Sanofi, Roche, and more the inaugural World Bispecific Summit Europe it’s set to be a key meeting point for teams driving discovery, engineering, CMC, safety, and clinical development of bispecifics.
Bionow's Neuroscience Conference brings together academics, clinicians and industry leaders to explore breakthroughs in the discovery, development and delivery of treatments for neurological diseases.
Innovate UK is hosting a full day Link & Learn event showcasing the Sustainable Medicines Manufacturing Innovation Programme (SMMIP) and the real-world impact its funded projects are set to deliver.
The event will bring together organisations across the medicines manufacturing sector to explore sustainable innovations and future adoption. The programme includes opportunities to link & learn directly with SMMIP projects, explore critical enablers for success and an evening networking session sponsored by ABPI.
ON Helix offers a high content mix of plenary talks and panels from key opinion leaders, Exhibition area, assembling an array of exhibitors; all great examples of helping to enable the translation of ideas into better patient outcomes.
Co-organisers, Professor Fiona Ducotterd, Alzheimer’s Research UK UCL Drug Discovery Institute, and Doctor Jim Ray, Belfer Neurodegeneration Consortium, MD Anderson Neuroscience Drug Discovery Institute, have curated this one-day Industry Masterclass in Drug Discovery and Development, hosted by Professor Mike Hanna, Director of Queen Square Institute of Neurology and Professor Sarah Tabrizi, Head of UCL Huntington’s Disease Research Centre, this day brings together stakeholders across sectors to share insights about the roles and disciplines that come together to make new medicines.
Best Practice AI for Life Sciences
Ready to separate the genuine AI signal from the hype? Join industry visionaries at the Wellcome Genome Campus in Hinxton, Cambridge, on 13 July for the Creative Disruption Forum. This interactive event targets what actually works—and what doesn't—when deploying machine learning across biotech and drug discovery.
Under strict Chatham House Rules, morning keynote panels transition into hands-on afternoon hackathons where you can workshop real-world tech implementation challenges with peers. If you are a biotech founder, R&D leader, or life sciences investor eager to master practical AI adoption, secure your place today. Let’s disrupt together.
Whether you're new to the field or looking to refine your skills, this 3-day hands-on training course ensures you're equipped to excel in an evolving industry. Featuring cutting-edge VR training supported by RESILIENCE, this course offers industry-relevant insights and real-world skills to advance your biotech career. The program includes both lectures and hands-on experience, covering the setup, steam sterilization in place (SIP), inoculation, monitoring, harvest, and SIP of a complete 30L yeast fermentation process.
To meet this need, Blanchard Lab engineers multicellular, stem cell–derived 3D human brain tissues that model key aspects of neurodegeneration in a physiologically relevant human context. They use these platforms to dissect disease mechanisms, identify therapeutic vulnerabilities, and accelerate translational discovery.
The UK government has identified engineering biology as a strategic priority within its Modern Industrial Strategy, recognising its potential to transform sectors from agriculture and food through to chemicals, materials, medicine and the environment. In recent years, there has been substantial investment through the National Engineering Biology Programme and UKRI’s mission‑led initiatives.
